Michael is a pharmacist by training and a turnaround expert with a strong record of healthcare innovation. He described the…
Read More »Martin Hensel
We spoke with Pieter Rottiers, Ph.D., CEO of ActoBio Therapeutics. Genetic testing, combined with existing NIH TrialNet procedures, has shown…
Read More »
Sernova is a regenerative medicine company located in London, Ontario. The corporation is led by President and CEO Dr. Philip…
Read More »
We exchanged email with Basanta. “My name is Basanta. I am a 32-year-old woman. I am in Nepal now.…
Read More »
We spoke with Marian Rewers, MD, Ph.D., Professor of Pediatrics & Medicine and Executive Director, Barbara Davis Center for Diabetes…
Read More »
We spoke with Anthony Coyle, Ph.D., Co-founder and CEO of Pandion Therapeutics which is located in Cambridge Massachusetts. This interview was…
Read More »
How do you see CGM devices evolving? The foundation of our product development is that we want our products to:…
Read More »
INTRODUCTION Virus infections have long been considered as a possible cause of type 1 diabetes. One virus group, enteroviruses (EVs),…
Read More »
Effective Therapeutic Rate A combination of two drugs enhances the production of beta cells such that they proliferate at the…
Read More »
Here is a good book for the new year! It is sure to give you some great ideas on how…
Read More »
Bonita was born in Ft. Sill, Oklahoma and moved often as an ‘Army brat’. She was diagnosed with T1D at…
Read More »
Diabetes care within schools is not great Many schools are underfunded and cannot afford school nurses or use staffing services…
Read More »
Prof. Dr. Henrik Semb who led the study explains his recent paper in Nature. Dr. Semb and his team have…
Read More »
JDRF and The Helmsley Charitable Trust announced collaborative grant agreement to provide Tidepool with the funding needed to begin developing…
Read More »
Kathleen and Jed have two children. Jeniya was diagnosed with T1D at age eleven and 18 months later Treshawn was…
Read More »
Islet transplants offer the hope of a permanent cure for Type 1 Diabetes. After nearly six years in stealth mode,…
Read More »
Andrew Lawless has written a new book on how a positive outlook and mindfulness can help you live a better…
Read More »
Oral delivery of insulin has been actively researched for decades. Injections are painful and inconvenient. People often delay starting insulin…
Read More »
When people with Type 2 Diabetes start basal insulin treatment, the goal is to reach a lower fasting glucose target.…
Read More »